100-Year-Old Becomes Oldest US Organ Donor
A 100-year-old WWII veteran became the oldest US organ donor, with his liver successfully transplanted, challenging age limits in donation.
Ayla Demirhan ·

A 100-year-old World War II veteran, Dale Steele, made history in February by becoming the oldest known organ donor in the United States. His liver was successfully transplanted, offering a new lease on life to a recipient, according to Live On Nebraska, an organ procurement organization. This remarkable event underscores a shift in organ donation criteria, emphasizing donor health and organ viability over chronological age.
Steele, who passed away following a head injury, served with distinction during World War II across multiple European theaters, including France, Germany, Belgium, and Czechoslovakia. His service extended to assisting concentration camp survivors and later guarding Nazi leaders during the Nuremberg trials. Following his military career, Steele returned to Nebraska, where he engaged in cattle farming and managed a farming cooperative.
Medical Breakthrough in Organ Donation
The decision to proceed with organ donation for a centenarian initially surprised Steele's son, Roger Steele. However, medical professionals clarified that the liver possesses a unique regenerative capacity, maintaining a cellular age that remains consistently young, irrespective of the donor's actual age. This biological characteristic is crucial for understanding the organ's suitability for transplantation.
Dr. Lee Morrow, Chief Medical Officer at Live On Nebraska, highlighted the role of advanced medical techniques in this successful transplantation. Specifically, warm blood perfusion, a method previously utilized for kidney transplants, was applied to Steele's liver. This innovative approach significantly enhanced the organ's viability, demonstrating its potential to broaden the donor pool.
Expanding the Donor Pool
This case challenges traditional perceptions regarding age limits for organ donation. It illustrates that medical advancements and a re-evaluation of age-related restrictions can lead to an expansion of available organs for transplantation. The successful outcome with Steele's liver suggests that more elderly individuals could potentially become donors, addressing the critical shortage of organs.
Organ procurement organizations are increasingly focusing on the physiological condition of organs rather than solely on the donor's age. This paradigm shift is vital for patients awaiting life-saving transplants. The successful transplantation of a liver from a 100-year-old donor provides a compelling example of how medical science continues to push boundaries, offering hope to those in need of organ transplants across the United States and globally.
Future Implications for Transplant Medicine
The implications of this case extend beyond individual success. It sets a precedent for future organ donation policies and practices, potentially leading to revised guidelines that prioritize organ health and function over arbitrary age cut-offs. This could significantly increase the number of viable organs available, reducing waitlist times and improving patient outcomes. The ongoing development and refinement of techniques like warm blood perfusion will be critical in realizing this potential.
Implications
Country Impact: This event could lead to a re-evaluation of organ donation age limits across the United States, potentially increasing the national donor pool and reducing transplant waitlists. It highlights advancements in medical techniques within the US healthcare system.
Industry Impact: The organ transplantation industry may see a shift in donor eligibility criteria, with greater emphasis on organ viability rather than chronological age. This could spur further research into organ preservation and assessment technologies.
Market Impact: While direct market impact is limited, increased donor availability could reduce long-term healthcare costs associated with chronic organ failure and dialysis. It may also stimulate investment in biotech firms developing organ assessment and preservation technologies.